Biomarkers of potential harm in people switching from smoking tobacco to exclusive e-cigarette use, dual use or abstinence: secondary analysis of Cochrane systematic review of trials of e-cigarettes for smoking cessation.
Individual Clinical
Biomarkers
Biomarkers Of Harm
hartmann-Boyce (2023)
Risk factors for early use of e-cigarettes and alcohol: Dimensions and profiles of temperament.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hartmann (2023)
Stimulus effects of propylene glycol and vegetable glycerin in electronic cigarette liquids.
Individual Clinical
Safety
Adverse Effects
harvanko (2019)
Twenty-four-hour subjective and pharmacological effects of ad-libitum electronic and combustible cigarette use among dual users.
Individual Clinical
Safety
Adverse Effects
harvanko (2020)
Biomarkers of exposure and potential harm in exclusive users of electronic cigarettes and current, former, and never smokers.
Individual Clinical
Biomarkers
ALL
haswell (2023)
Impact of Chewing Bags, E-Cigarettes, and Combustible Cigarettes on arterial Stiffness and Small airway Function in healthy Students.
Individual Clinical
Safety
Adverse Effects
hauck (2023)
Use of ENDS and Cigarettes During Pregnancy.
Individual Clinical
Safety
Adverse Effects
hawkins (2020)
Patterns of Smoking Behaviour in Low-Income Pregnant Women: a Cohort Study of Differential Effects on Infant Birth Weight
Individual Clinical
Safety
Adverse Effects
hayes (2016)
Characterizing Gas Exchange Physiology in healthy Young Electronic-Cigarette Users with hyperpolarized 129Xe MRI: a Pilot Study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
he (2021)
Electronic cigarette exposure disrupts blood-brain barrier integrity and promotes neuroinflammation.
Individual Clinical
Safety
Adverse Effects
heldt (2020)